KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,657 JPY | -0.47% |
|
+1.01% | +12.11% |
| Apr. 08 | U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease | RE |
| Apr. 03 | Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,670
JPY
Average target price
3,067
JPY
Spread / Average Target
+14.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.11% | 9.26B | |
| +4.86% | 70.36B | |
| -16.73% | 4.72B | |
| +23.84% | 3.89B | |
| +1.45% | 3.75B | |
| +29.79% | 2.66B | |
| -24.17% | 2.37B | |
| -27.04% | 2.17B | |
| -3.78% | 1.75B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
- News Kyowa Kirin Co. Ltd.
- Kyowa Kirin : to Issue Shares Worth Nearly $2 Million as Stock Compensation to Employees
